FIELD: biotechnologies.
SUBSTANCE: vector is proposed for controlled expression of protein, having a function of interleukine-12, and also the method to produce modified in vitro dendrite cells and appropriate cells, which express interleukin-12 in a controlled manner, under control of the system of gen expression modulation in presence of activating ligand.
EFFECT: invention may be used in therapy for treatment of animals, including a human being.
Authors
Dates
2013-06-10—Published
2008-10-08—Filed